Archive for TDM-1

ASCO update: making chemotherapy more tolerable by making it more targeted

Saturday, June 2nd, 2012

TV celebrity Suzanne Somers was treated for breast cancer herself, and has openly spoken about what she called the “vast and often pointless use of chemotherapy” (Huffington Post, 2009). This comment refers to the great suffering inflicted on many women by the side effects of chemotherapy, when the therapeutic gain in extended lifespan is minimal. ... read more »

New developments in metastatic breast cancer to be reported at ASCO 2012 meeting in Chicago

Monday, May 21st, 2012

Biotechnology pioneer company Genentech is moving ahead with its latest advance in the treatment of metastatic breast cancer. Data from its newest therapy, TDM-1, will be showcased at the premier annual cancer meeting in America called ASCO (American Society for Clinical Oncology) on June 1-5, 2012 in Chicago. Data is being presented from the pivotal ... read more »